<DOC>
	<DOC>NCT01780077</DOC>
	<brief_summary>The purpose of this trial is to evaluate the safety and tolerability of multiple (3) intradermal doses of RXI-109 at small surgical incisions in the abdominal skin of healthy volunteers. The effect of RXI-109 versus placebo on scarring at these incision sites will be evaluated visually, histologically, and by biomarker analysis.</brief_summary>
	<brief_title>Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<criteria>Males and females, 2150 years of age General good health; if female not pregnant or lactating Phototype 3 and above based on the Fitzpatrick scale. Pregnant or lactating Use of tobacco or nicotinecontaining products within 1 month prior to enrollment and while on study Type 1 or 2 diabetes mellitus A history or presence of any medical condition or therapy that would make the subject an unsafe candidate in the opinion of the investigator</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Scar</keyword>
	<keyword>Scar prevention</keyword>
	<keyword>Fibrosis</keyword>
</DOC>